Founded in 2012, we are the leading pharmatech company and the first to automate drug discovery. As a full stack AI drug discovery company, we generate our own data before combining the analytical power of AI with the creativity and expertise of our world-class scientists. This allows us to shorten the pre-clinical drug discovery stage by at least three-quarters and, in turn, substantially accelerate the delivery of new treatments to patients worldwide.
Bill & Melinda Gates Foundation & SoftBank
Bristol-Myers Squibb, Novo Holdings & GT Healthcare
SoftBank Vision Fund 2i, Novo Holdings & Blackrock